Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Completed · Phase 2

Conditions studied: HIV Infections, H1N1 Influenza Virus

In brief

Both pregnant women and people infected with HIV are at increased risk of viral infection, including influenza infection. Pregnant women infected with HIV may be at particular risk of infection from the new H1N1 influenza virus. This study tested the safety and immunogenicity of an H1N1 influenza vaccine in pregnant women infected with HIV.

Key facts

Study ID
NCT00992017
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
130
Starts
2009-10-01
Expected to finish
2010-11-01
Last updated by the study team
2021-11-05

Who can join

Age: 18 and older, up to 39. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.